252 results on '"Armstrong, Paul W."'
Search Results
2. Baseline Q-Wave Surpasses Time From Symptom Onset as a Prognostic Marker in ST-Segment Elevation Myocardial Infarction Patients Treated With Primary Percutaneous Coronary Intervention
3. Declining In-Hospital Mortality and Increasing Heart Failure Incidence in Elderly Patients With First Myocardial Infarction
4. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction
5. In Memoriam: James T. Willerson, 1939 to 2020
6. Short- and Long-Term Risk Stratification in Acute Coronary Syndromes: The Added Value of Quantitative ST-Segment Depression and Multiple Biomarkers
7. Effects of Selective Matrix Metalloproteinase Inhibitor (PG-116800) to Prevent Ventricular Remodeling After Myocardial Infarction: Results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) Trial
8. Post-Discharge Bleeding and Mortality Following Acute Coronary Syndromes With or Without PCI
9. Aborted myocardial infarction in patients with ST-segment elevation: Insights from the assessment of the safety and efficacy of a new thrombolytic regimen-3 trial electrocardiographic substudy
10. Outcome of acute ST-segment elevation myocardial infarction in diabetics treated with fibrinolytic or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: Lessons from the GUSTO V trial
11. Prognostic significance of elevated troponin i after percutaneous coronary intervention
12. The prognostic value of creatine kinase elevations extends across the whole spectrum of acute coronary syndromes
13. Physical Activity and Mortality in Patients With Stable Coronary Heart Disease
14. A Natural Biomarker Deserving Attention
15. Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease
16. Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure
17. Navigating Choices Among a Sea of Comorbidities ∗
18. Cardiovascular drug development: is it dead or just hibernating?
19. Searching for Adherence
20. Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes
21. THE RELATIONSHIP BETWEEN BODY WEIGHT CHANGE DURING HOSPITALIZATION FOR ACUTE HEART FAILURE AND PATIENT CHARACTERISTICS, MARKERS OF CONGESTION, AND OUTCOMES: FINDINGS FROM ASCEND-HF
22. Spontaneous MI After Non–ST-Segment Elevation Acute Coronary Syndrome Managed Without Revascularization
23. Impact of CYP2C19 Metabolizer Status on Patients With ACS Treated With Prasugrel Versus Clopidogrel
24. Transatlantic Comparison of ST-Segment Elevation Myocardial Infarction Guidelines
25. Cardiovascular Drug Development
26. INTERLEUKIN-6 IS ASSOCIATED WITH, BUT DOES NOT INDEPENDENTLY PREDICT, MORTALITY IN ACUTE HEART FAILURE: AN ASCEND-HF SUBSTUDY
27. Vorapaxar in Acute Coronary Syndrome Patients Undergoing Coronary Artery Bypass Graft Surgery
28. Left Bundle Branch Block in Non–ST-Segment Elevation Acute Coronary Syndromes
29. Comparison of the Prognosis of Spontaneous and Percutaneous Coronary Intervention–Related Myocardial Infarction
30. Third Universal Definition of Myocardial Infarction
31. Assessment of Dyspnea in Acute Decompensated Heart Failure
32. ASSOCIATION OF HUB AND SPOKE PRACTICE PATTERNS WITH CORONARY INTERVENTION AND OUTCOMES IN NON ST ELEVATION ACUTE CORONARY SYNDROMES (NSTE ACS): INSIGHTS FROM THE EARLY GLYCOPROTEIN IIB/IIIA INHIBITION IN NSTE ACS (EARLY-ACS) TRIAL
33. WHAT THRESHOLD SHOULD BE USED TO DEFINE PERCUTANEOUS CORONARY INTERVENTION-RELATED MYOCARDIAL INFARCTION? AN APPROACH BASED ON CLINICAL RELEVANCE FROM EARLY ACS AND SYNERGY
34. SERIOUS INFECTIONS IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION TREATED WITH PRIMARY PCI ARE RARE, BUT ASSOCIATED WITH HIGHER MORTALITY
35. EFFECT OF TESTOSTERONE SUPPLEMENTATION ON EXERCISE CAPACITY IN HEART FAILURE PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
36. Association of Mortality With Years of Education in Patients With ST-Segment Elevation Myocardial Infarction Treated With Fibrinolysis
37. Testosterone Therapy in Women With Heart Failure
38. ST-Segment Resolution and Outcome in Myocardial Infarction
39. IS VISUAL INTERPRETATION OF CORONARY EPICARDIAL FLOW RELIABLE IN ST ELEVATION MYOCARDIAL INFARCTION PATIENTS UNDERGOING PRIMARY ANGIOPLASTY? INSIGHTS FROM APEX-AMI
40. SUSTAINED VENTRICULAR ARRHYTHMIAS ADD PROGNOSTIC VALUE INDEPENDENT OF UNDERLYING RISK IN STEMI PATIENTS UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION
41. SEX DIFFERENCES IN HIGH-RISK ACUTE CORONARY SYNDROMES: INSIGHTS FROM EARLY-ACS
42. EARLY PCI AFTER THROMBOLYSIS VERSUS STANDARD THERAPY IN STEMI PATIENTS: A CUMULATIVE META-ANALYSIS
43. QRS SCORE AT HOSPITAL DISCHARGE IS A STRONG PROGNOSTIC MARKER IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION
44. SAFETY AND EFFICACY OF ADJUSTED-DOSE EPTIFIBATIDE IN PATIENTS WITH ACUTE CORONARY SYNDROMES AND REDUCED RENAL FUNCTION
45. INTERACTION BETWEEN TIME TO TREATMENT AND TYPE OF REPERFUSION THERAPY IN STEMI: A POOLED ANALYSIS OF ONE-YEAR MORTALITY IN THE COMPARISON OF ANGIOPLASTY & PREHOSPITAL THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTION (CAPTIM) AND WHICH EARLY ST-ELEVATION MYOCARDIAL INFARCTION THERAPY (WEST) TRIALS
46. TEMPORAL TRENDS OVER 15 YEARS IN CLINICAL TRIALS OF NON-ST ELEVATION ACUTE CORONARY SYNDROMES: MORE AGGRESSIVE TREATMENT YIELDS SIMILAR MORTALITY DESPITE HIGHER-RISK PROFILES
47. UPFRONT CLOPIDOGREL USE AND THE EFFICACY AND SAFETY OF EARLY EPTIFIBATIDE USE IN PATIENTS WITH ACUTE CORONARY SYNDROME: AN ANALYSIS FROM THE EARLY VERSUS DELAYED PROVISIONAL EPTIFIBATIDE IN ACUTE CORONARY SYNDROMES (EARLY ACS) TRIAL
48. Reply
49. Nebivolol in Older Adults With Heart Failure
50. Physiologic Straws in the Wind
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.